GSK’s New Research Chief Begins Leadership With Expanded Genomics/AI Alliance
Doubles Down On Precision Medicine
GSK’s new chief scientific officer Tony Wood is building on the precision medicine approach by partnering with Tempus to accelerate cancer drug trials and improve the firm’s R&D productivity.
